Quick Links

 Selected Publications

Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Blume KG, Forman SJ.  Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.  New England Journal of Medicine 1993; 329:1225-1230.

Niland JC, Gebhardt JA, Lee J, Forman SJ.  Study design, statistical analyses, and results reporting in the bone marrow transplantation literature.  Biology of Blood and Marrow Transplantation 1995;1:47-53.

Nademanee A, Molina A, O’Donnell MR, Dagis A, Snyder DS, Parker P, Stein AS, Smith E, Planas I, Kashyap A, Spielberger R, Fung HC, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Blume KG, Niland JC,Forman SJ.  Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate and high-grade lymphoma: international index high and high-intermediate risk group.  Blood 1997; 90:10:3844-3852.

Niland JC.  NCCN Outcomes Research Database:  The First Two Years of Data Collection and Analysis.  Oncology, 1999; 13; 11A.

Chao NJ, Snyder DS, Jain M, Wong RM, Niland JC, Negrin RS, Long GD, Hu WW, Stockerl-Goldstein KE, Johnston LJ, Amylon MD, Tierney DK, O'Donnell MR, Nademanee AP, Parker P, Stein A, Molina A, Fung H. Kashyap A, Kohler S, Spielberger R, Krishnan A, Rodriguez R, Forman SJ, Blume KG.  Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.  Biology of Blood and Marrow Transplantation 2000;6:254-261.

Stahl DC, Stahl CL, Niland JC. Evaluating the impact of Clinical Trials On-Line on clinical trial awareness and accrual Proceedings of the 33rd Annual Hawaii International Conference on System Sciences, 110, 2000.

Bhatia, S, Louie, AD, Bhatia, R, O'Donnell, MR, Fung, H, Kashyap, A, Molina, A, Nademanee, A, Niland, JC, Parker, PA, Sniecinski, I, Snyder DS, Spielberger, R, Stein, A, Forman, SJ.  Solid cancers following bone marrow transplantation.  Journal of Clinical Oncology 2001 1:15; 19(2): 464-71.

Arber, DA, Snyder DS, Fine M, Dagis A, Niland JC, Slovak ML.  Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. American Journal of Clinical Pathology 2001; 116:25-33.

Deapen D, Menck H R, Ervin I, Leventhal M, Niland JC.  Experience in developing E-path cancer reporting for rapid case ascertainment.  Journal of Registry Management 2002; 29(2): 44-51.

Niland JC, Stahl DC.  Increasing clinical trial awareness and accrual via the web.  In Silva J, Ball MJ, Chute C, Langlotz E, Niland JC, Scherlis W, Douglas JV, Editors.  Cancer Informatics: Essential Technologies for Clinical Trials, Springer Verlag, 2002.

Chang KL, O'Donnell M, Slovak M, Dagis A, Arber DA, Niland JC, Forman SJ.  Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.  Leukemia, 2002; 16(4): 623-631.

Stein AS, Donnell MR, Slovak ML, Snyder DS, Nademanee AP, Parker P, Molina A, Somlo G, Fung HC, Krishnan A, Rodriguez R, Spielberger RT, Wang S, Dagis A, Vora N, Arber DA, Niland JC, Forman SJ: Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. Journal of Clinical Oncology, 2003; 21: 615-623.

Edge S, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks J.  Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers.  Journal of the National Cancer Institute, 2003; 95 (20):1514-1521.

Weinstein SM, Romanus D, Lepisto EM, Reyes-Gibby C, Cleeland C, Greene R, Muir C, Niland JC.  Documentation of pain in comprehensive cancer centers in the United States: a preliminary analysis.  Journal of the National Comprehensive Cancer Network, 2004; 2(2): 173-180.

Bucholz T, Theriault R, Niland JC, Hughes M, Ottesen R, Edge S, Bookman M, Weeks JC. The Use of Radiation as a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers.  Journal of Clinical Oncology, 2006; 24(3): 361-369.

Christian CK, Edge S, MD, Niland JC, Ottesen R, Hughes M, Wilson J, Hergeuter C, Weeks JC.  A Multi-institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction.: A Study of the National Comprehensive Cancer Network” Ann Surg 2006; 243: 241-249

Niland JC, Rouse L, Stahl DC. An Informatics Blueprint for Healthcare Quality Information Systems. J Am Med Inform Assoc. 2006;13: 402-417

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.

 

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.